These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4362265)

  • 1. [Study of the biological properties of vaccinal strains of type 3 poliomyelitis virus isolated from children in Sverdlovsk].
    Shchekochikhina EA; Dodonova NN; Dzagurov SG; Omel'chenko TN; Tsetlin EM
    Vopr Virusol; 1973; 18(4):484-9. PubMed ID: 4362265
    [No Abstract]   [Full Text] [Related]  

  • 2. Serodifferentiation of poliovirus strains. II. Modified Wecker test on type 3 poliovirus strains.
    Soda K; Kitahara T; Nakao C; Hara M; Tagaya I
    Jpn J Med Sci Biol; 1969 Aug; 22(4):201-16. PubMed ID: 4311582
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic characterization of poliovirus strains by neutralization kinetic studies and the modified Wecker technique.
    Nakao C
    Jpn J Med Sci Biol; 1969 Aug; 22(4):217-33. PubMed ID: 4311583
    [No Abstract]   [Full Text] [Related]  

  • 4. Poliovirus antibody differentiation. Methods and application for strain specific diagnosis in complications after oral vaccination.
    Kuwert E; Höher PG; Thraenhart O
    Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):407-12. PubMed ID: 180727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [100 years of studying poliomyelitis virus and nonpoliomyelitis enteroviruses].
    Lashkevich VA
    Vopr Virusol; 2008; 53(4):41-4. PubMed ID: 18756817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

  • 7. [Findings of virus-neutralizing antibodies against polioviruses in the population of Slovakia 9 and 12 years following introduction of immunization by attenuated polioviruses (author's transl)].
    Borská K; Mayerová A; Masár I; Svanigová L; Roda J; Lukácová V
    Bratisl Lek Listy; 1976 Apr; 65(4):400-6. PubMed ID: 183864
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity induced by inactivated poliovirus vaccine and excretion of virus.
    Chin TD
    Rev Infect Dis; 1984; 6 Suppl 2():S369-70. PubMed ID: 6330838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the mutagenic action of proflavine on type 3 poliovirus.
    Pervikov YV; Vorohsilova MK; Chumakov MP; Savinov AP; Yurovetskaya AL
    Acta Virol; 1973 Jul; 17(4):365. PubMed ID: 4148222
    [No Abstract]   [Full Text] [Related]  

  • 11. Poliovirus type 3 isolation from infants with respiratory diseases.
    Sărăţeanu D; Popescu G; Botiş S; Baba C
    Rev Roum Virol (1972); 1973; 10(3):227-32. PubMed ID: 4359718
    [No Abstract]   [Full Text] [Related]  

  • 12. New trends in the preparation of cell substrates for the production of virus vaccines.
    van Wezel AL
    Prog Immunobiol Stand; 1971; 5():187-92. PubMed ID: 4349819
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preparation and use of inactivated vaccine against acute anterior poliomyelitis in the Netherlands].
    van Wezel AL; van Steenis G; Hannik CA; Kapsenberg JG; Hofman B; Cohen H
    Ned Tijdschr Geneeskd; 1979 Mar; 123(12):466-74. PubMed ID: 424009
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.
    Bull World Health Organ; 1969; 40(6):925-45. PubMed ID: 4310724
    [No Abstract]   [Full Text] [Related]  

  • 15. Poliomyelitis in Rio de Janeiro during the period of 1970 to 1974. I. Virological and epidemiological aspects.
    Von Hubinger MG; Meilman I; Guimarães JC; De Vascancelos CM; Liberto MI
    An Microbiol (Rio J); 1978; 23():35-50. PubMed ID: 233609
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on new attenuated strains of type III live poliomyelitis vaccine. I. Development of a new type III attenuated poliovirus.
    Chin Med J (Engl); 1980 Sep; 93(9):583-90. PubMed ID: 6253236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
    Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
    [No Abstract]   [Full Text] [Related]  

  • 18. The detection of different progenies induced by fractionated infectious poliovirus RNA.
    Koza J
    Med Microbiol Immunol; 1973; 158(4):317-24. PubMed ID: 4354972
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
    Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
    Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.